Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

A case of idiopathic unilateral oculomotor nerve palsy with good outcome.

Mitchell J, Fuhrman S, Gersh DB.

Vet Radiol Ultrasound. 2019 Nov;60(6):755. doi: 10.1111/vru.12804. Epub 2019 Sep 11. No abstract available.

PMID:
31509892
2.

Nutrition surveillance in emergency contexts: South Sudan case study.

Michalska A, Leidman E, Fuhrman S, Mwirigi L, Bilukha O, Basquin C.

Field Exch. 2015 Aug;50:73. No abstract available.

3.

Interference between postural control and spatial vs. non-spatial auditory reaction time tasks in older adults.

Fuhrman SI, Redfern MS, Jennings JR, Furman JM.

J Vestib Res. 2015;25(2):47-55. doi: 10.3233/VES-150546.

PMID:
26410669
4.

ICU Telemedicine Solutions.

Fuhrman SA, Lilly CM.

Clin Chest Med. 2015 Sep;36(3):401-7. doi: 10.1016/j.ccm.2015.05.004. Epub 2015 Jun 27. Review.

PMID:
26304277
5.

Erratum to: postural adjustment errors during lateral step initiation in older and younger adults.

Sparto PJ, Fuhrman SI, Redfern MS, Perera S, Jennings JR, Alghwiri AA, Furman JM.

Exp Brain Res. 2015 Apr;233(4):1351. doi: 10.1007/s00221-014-4162-z. No abstract available.

6.

Postural adjustment errors during lateral step initiation in older and younger adults.

Sparto PJ, Fuhrman SI, Redfern MS, Perera S, Richard Jennings J, Alghwiri AA, Furman JM.

Exp Brain Res. 2014 Dec;232(12):3977-89. doi: 10.1007/s00221-014-4081-z. Epub 2014 Sep 3. Erratum in: Exp Brain Res. 2015 Apr;233(4):1351. Alghwiri, Alia A [added].

7.

Neuroimaging to detect cortical projection of vestibular response to caloric stimulation in young and older adults using functional near-infrared spectroscopy (fNIRS).

Karim HT, Fuhrman SI, Furman JM, Huppert TJ.

Neuroimage. 2013 Aug 1;76:1-10. doi: 10.1016/j.neuroimage.2013.02.061. Epub 2013 Mar 22.

8.

Functional brain imaging of multi-sensory vestibular processing during computerized dynamic posturography using near-infrared spectroscopy.

Karim H, Fuhrman SI, Sparto P, Furman J, Huppert T.

Neuroimage. 2013 Jul 1;74:318-25. doi: 10.1016/j.neuroimage.2013.02.010. Epub 2013 Feb 16.

9.

Intensive care unit-acquired hypernatremia is an independent predictor of increased mortality and length of stay.

Waite MD, Fuhrman SA, Badawi O, Zuckerman IH, Franey CS.

J Crit Care. 2013 Aug;28(4):405-12. doi: 10.1016/j.jcrc.2012.11.013. Epub 2013 Jan 29.

PMID:
23369520
10.

Visual-vestibular stimulation influences spatial and non-spatial cognitive processing.

Furman JM, Redfern MS, Fuhrman SI, Jennings JR.

J Vestib Res. 2012;22(5-6):253-9. doi: 10.3233/VES-2012-00460.

11.

Postural adjustment errors reveal deficits in inhibition during lateral step initiation in older adults.

Sparto PJ, Fuhrman SI, Redfern MS, Jennings JR, Perera S, Nebes RD, Furman JM.

J Neurophysiol. 2013 Jan;109(2):415-28. doi: 10.1152/jn.00682.2012. Epub 2012 Oct 31.

12.

Association between intensive care unit-acquired dysglycemia and in-hospital mortality.

Badawi O, Waite MD, Fuhrman SA, Zuckerman IH.

Crit Care Med. 2012 Dec;40(12):3180-8. doi: 10.1097/CCM.0b013e3182656ae5.

PMID:
22971590
13.

Guidelines for the use of wheelchair postural support devices during travel in motor vehicles.

Karg P, Cotzin B, Manary M, Fuhrman SI.

J Pediatr Rehabil Med. 2011;4(4):251-7. doi: 10.3233/PRM-2011-0182.

PMID:
22430621
14.

State of the science workshop on wheelchair transportation safety.

Karg P, Buning ME, Bertocci G, Fuhrman S, Hobson D, Manary M, Schneider L, van Roosmalen L.

Assist Technol. 2009 Fall;21(3):115-60. doi: 10.1080/10400430903175663.

PMID:
19908679
15.

Characterization of pediatric wheelchair kinematics and wheelchair tiedown and occupant restraint system loading during rear impact.

Fuhrman SI, Karg P, Bertocci G.

Med Eng Phys. 2010 Apr;32(3):280-6. doi: 10.1016/j.medengphy.2009.03.006. Epub 2009 Apr 23.

PMID:
19398366
16.

Tablet and inhaled controller medication refill frequencies in children with asthma.

Fitzpatrick AM, Kir T, Naeher LP, Fuhrman SC, Hahn K, Teague WG.

J Pediatr Nurs. 2009 Apr;24(2):81-9. doi: 10.1016/j.pedn.2008.02.027. Epub 2008 Jun 20.

PMID:
19268230
17.

Effect of wheelchair headrest use on pediatric head and neck injury risk outcomes during rear impact.

Fuhrman SI, Karg PE, Bertocci GE.

Accid Anal Prev. 2008 Jul;40(4):1595-603. doi: 10.1016/j.aap.2008.04.007. Epub 2008 May 19.

PMID:
18606295
18.

In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Shi ST, Herlihy KJ, Graham JP, Fuhrman SA, Doan C, Parge H, Hickey M, Gao J, Yu X, Chau F, Gonzalez J, Li H, Lewis C, Patick AK, Duggal R.

Antimicrob Agents Chemother. 2008 Feb;52(2):675-83. Epub 2007 Dec 10.

19.

Allosteric inhibitors of hepatitis C polymerase: discovery of potent and orally bioavailable carbon-linked dihydropyrones.

Li H, Linton A, Tatlock J, Gonzalez J, Borchardt A, Abreo M, Jewell T, Patel L, Drowns M, Ludlum S, Goble M, Yang M, Blazel J, Rahavendran R, Skor H, Shi S, Lewis C, Fuhrman S.

J Med Chem. 2007 Aug 23;50(17):3969-72. Epub 2007 Jul 21.

PMID:
17658778
20.

Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.

Hao W, Herlihy KJ, Zhang NJ, Fuhrman SA, Doan C, Patick AK, Duggal R.

Antimicrob Agents Chemother. 2007 Jan;51(1):95-102. Epub 2006 Oct 23.

21.

Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors.

Li H, Tatlock J, Linton A, Gonzalez J, Borchardt A, Dragovich P, Jewell T, Prins T, Zhou R, Blazel J, Parge H, Love R, Hickey M, Doan C, Shi S, Duggal R, Lewis C, Fuhrman S.

Bioorg Med Chem Lett. 2006 Sep 15;16(18):4834-8. Epub 2006 Jul 7.

PMID:
16824756
22.

In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.

Patick AK, Brothers MA, Maldonado F, Binford S, Maldonado O, Fuhrman S, Petersen A, Smith GJ 3rd, Zalman LS, Burns-Naas LA, Tran JQ.

Antimicrob Agents Chemother. 2005 Jun;49(6):2267-75.

23.

Analytic bias of thyroid function tests: analysis of a College of American Pathologists fresh frozen serum pool by 3900 clinical laboratories.

Steele BW, Wang E, Klee GG, Thienpont LM, Soldin SJ, Sokoll LJ, Winter WE, Fuhrman SA, Elin RJ.

Arch Pathol Lab Med. 2005 Mar;129(3):310-7.

PMID:
15737023
24.

The crystal structure of the RNA-dependent RNA polymerase from human rhinovirus: a dual function target for common cold antiviral therapy.

Love RA, Maegley KA, Yu X, Ferre RA, Lingardo LK, Diehl W, Parge HE, Dragovich PS, Fuhrman SA.

Structure. 2004 Aug;12(8):1533-44.

25.

An optical thin film assay incorporating rhinovirus protease inhibitors as detector reagents.

Ettinger A, Ostroff R, Rhihanek M, Dragovich PS, Zalman LS, Patick AK, Prins TJ, Fuhrman SA, Brown EL, Worland ST, Polisky B.

Antiviral Res. 2004 Mar;61(3):153-9.

PMID:
15168795
26.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.

Dragovich PS, Prins TJ, Zhou R, Johnson TO, Hua Y, Luu HT, Sakata SK, Brown EL, Maldonado FC, Tuntland T, Lee CA, Fuhrman SA, Zalman LS, Patick AK, Matthews DA, Wu EY, Guo M, Borer BC, Nayyar NK, Moran T, Chen L, Rejto PA, Rose PW, Guzman MC, Dovalsantos EZ, Lee S, McGee K, Mohajeri M, Liese A, Tao J, Kosa MB, Liu B, Batugo MR, Gleeson JP, Wu ZP, Liu J, Meador JW 3rd, Ferre RA.

J Med Chem. 2003 Oct 9;46(21):4572-85.

PMID:
14521419
27.

Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme.

Love RA, Parge HE, Yu X, Hickey MJ, Diehl W, Gao J, Wriggers H, Ekker A, Wang L, Thomson JA, Dragovich PS, Fuhrman SA.

J Virol. 2003 Jul;77(13):7575-81. Erratum in: J Virol. 2003 Sep;77(18):10176.

28.

Spearman correlation identifies statistically significant gene expression clusters in spinal cord development and injury.

Kotlyar M, Fuhrman S, Ableson A, Somogyi R.

Neurochem Res. 2002 Oct;27(10):1133-40.

PMID:
12462411
29.

Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease.

Johnson TO, Hua Y, Luu HT, Brown EL, Chan F, Chu SS, Dragovich PS, Eastman BW, Ferre RA, Fuhrman SA, Hendrickson TF, Maldonado FC, Matthews DA, Meador JW 3rd, Patick AK, Reich SH, Skalitzky DJ, Worland ST, Yang M, Zalman LS.

J Med Chem. 2002 May 9;45(10):2016-23.

PMID:
11985469
30.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics.

Dragovich PS, Prins TJ, Zhou R, Brown EL, Maldonado FC, Fuhrman SA, Zalman LS, Tuntland T, Lee CA, Patick AK, Matthews DA, Hendrickson TF, Kosa MB, Liu B, Batugo MR, Gleeson JP, Sakata SK, Chen L, Guzman MC, Meador JW 3rd, Ferre RA, Worland ST.

J Med Chem. 2002 Apr 11;45(8):1607-23.

PMID:
11931615
31.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics.

Dragovich PS, Prins TJ, Zhou R, Johnson TO, Brown EL, Maldonado FC, Fuhrman SA, Zalman LS, Patick AK, Matthews DA, Hou X, Meador JW, Ferre RA, Worland ST.

Bioorg Med Chem Lett. 2002 Mar 11;12(5):733-8.

PMID:
11858991
32.
33.

Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors.

Webber SE, Marakovits JT, Dragovich PS, Prins TJ, Zhou R, Fuhrman SA, Patick AK, Matthews DA, Lee CA, Srinivasan B, Moran T, Ford CE, Brothers MA, Harr JE, Meador JW 3rd, Ferre RA, Worland ST.

Bioorg Med Chem Lett. 2001 Oct 22;11(20):2683-6.

PMID:
11591501
34.

Vancomycin-resistant organisms on a burn unit.

Still J, Law E, Friedman B, Fuhrman S, Newton T.

South Med J. 2001 Aug;94(8):810-2.

PMID:
11549193
35.

Gene expression microarray data analysis for toxicology profiling.

Cunningham MJ, Liang S, Fuhrman S, Seilhamer JJ, Somogyi R.

Ann N Y Acad Sci. 2000;919:52-67.

PMID:
11083097
36.

Immunoglobulin E: importance in parasitic infections and hypersensitivity responses.

Winter WE, Hardt NS, Fuhrman S.

Arch Pathol Lab Med. 2000 Sep;124(9):1382-5. Review. No abstract available.

PMID:
10975945
37.

Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation.

Reich SH, Johnson T, Wallace MB, Kephart SE, Fuhrman SA, Worland ST, Matthews DA, Hendrickson TF, Chan F, Meador J 3rd, Ferre RA, Brown EL, DeLisle DM, Patick AK, Binford SL, Ford CE.

J Med Chem. 2000 May 4;43(9):1670-83.

PMID:
10794684
38.

The application of shannon entropy in the identification of putative drug targets.

Fuhrman S, Cunningham MJ, Wen X, Zweiger G, Seilhamer JJ, Somogyi R.

Biosystems. 2000 Feb;55(1-3):5-14.

PMID:
10745103
39.

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors.

Dragovich PS, Zhou R, Webber SE, Prins TJ, Kwok AK, Okano K, Fuhrman SA, Zalman LS, Maldonado FC, Brown EL, Meador JW 3rd, Patick AK, Ford CE, Brothers MA, Binford SL, Matthews DA, Ferre RA, Worland ST.

Bioorg Med Chem Lett. 2000 Jan 3;10(1):45-8.

PMID:
10636240
40.

In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.

Patick AK, Binford SL, Brothers MA, Jackson RL, Ford CE, Diem MD, Maldonado F, Dragovich PS, Zhou R, Prins TJ, Fuhrman SA, Meador JW, Zalman LS, Matthews DA, Worland ST.

Antimicrob Agents Chemother. 1999 Oct;43(10):2444-50.

41.

Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.

Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, Hendrickson TF, Love RA, Prins TJ, Marakovits JT, Zhou R, Tikhe J, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, Brothers MA, DeLisle DM, Worland ST.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11000-7.

42.

Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids.

Dragovich PS, Webber SE, Prins TJ, Zhou R, Marakovits JT, Tikhe JG, Fuhrman SA, Patick AK, Matthews DA, Ford CE, Brown EL, Binford SL, Meador JW 3rd, Ferre RA, Worland ST.

Bioorg Med Chem Lett. 1999 Aug 2;9(15):2189-94.

PMID:
10465543
43.

Linear modeling of mRNA expression levels during CNS development and injury.

D'haeseleer P, Wen X, Fuhrman S, Somogyi R.

Pac Symp Biocomput. 1999:41-52.

44.

Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides.

Dragovich PS, Zhou R, Skalitzky DJ, Fuhrman SA, Patick AK, Ford CE, Meador JW 3rd, Worland ST.

Bioorg Med Chem. 1999 Apr;7(4):589-98.

PMID:
10353638
45.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.

Dragovich PS, Prins TJ, Zhou R, Webber SE, Marakovits JT, Fuhrman SA, Patick AK, Matthews DA, Lee CA, Ford CE, Burke BJ, Rejto PA, Hendrickson TF, Tuntland T, Brown EL, Meador JW 3rd, Ferre RA, Harr JE, Kosa MB, Worland ST.

J Med Chem. 1999 Apr 8;42(7):1213-24.

PMID:
10197965
46.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.

Dragovich PS, Prins TJ, Zhou R, Fuhrman SA, Patick AK, Matthews DA, Ford CE, Meador JW 3rd, Ferre RA, Worland ST.

J Med Chem. 1999 Apr 8;42(7):1203-12.

PMID:
10197964
47.

Interaction of a novel GDP exchange inhibitor with the Ras protein.

Ganguly AK, Wang YS, Pramanik BN, Doll RJ, Snow ME, Taveras AG, Remiszewski S, Cesarz D, del Rosario J, Vibulbhan B, Brown JE, Kirschmeier P, Huang EC, Heimark L, Tsarbopoulos A, Girijavallabhan VM, Aust RM, Brown EL, DeLisle DM, Fuhrman SA, Hendrickson TF, Kissinger CR, Love RA, Sisson WA, Webber SE, et al.

Biochemistry. 1998 Nov 10;37(45):15631-7.

PMID:
9843367
48.

Cluster analysis and data visualization of large-scale gene expression data.

Michaels GS, Carr DB, Askenazi M, Fuhrman S, Wen X, Somogyi R.

Pac Symp Biocomput. 1998:42-53.

49.
50.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies.

Dragovich PS, Webber SE, Babine RE, Fuhrman SA, Patick AK, Matthews DA, Reich SH, Marakovits JT, Prins TJ, Zhou R, Tikhe J, Littlefield ES, Bleckman TM, Wallace MB, Little TL, Ford CE, Meador JW 3rd, Ferre RA, Brown EL, Binford SL, DeLisle DM, Worland ST.

J Med Chem. 1998 Jul 16;41(15):2819-34.

PMID:
9667971

Supplemental Content

Loading ...
Support Center